These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26680638)

  • 21. [Burning mouth syndrome].
    Schatton R; Riechelmann H
    Laryngorhinootologie; 2007 Jun; 86(6):454-60; quiz 461-2. PubMed ID: 17541900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of treatment modalities in burning mouth syndrome.
    Barker KE; Batstone MD; Savage NW
    Aust Dent J; 2009 Dec; 54(4):300-5; quiz 396. PubMed ID: 20415927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical clonazepam for burning mouth syndrome: Is it efficacious in patients with anxiety or depression?
    Rossella I; Alessandro V; Naman R; Gary K; Hervé SY
    J Oral Rehabil; 2022 Jan; 49(1):54-61. PubMed ID: 34716948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatments for Burning Mouth Syndrome: A Network Meta-analysis.
    Alvarenga-Brant R; Costa FO; Mattos-Pereira G; Esteves-Lima RP; Belém FV; Lai H; Ge L; Gomez RS; Martins CC
    J Dent Res; 2023 Feb; 102(2):135-145. PubMed ID: 36214096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of treatment for patients with burning mouth syndrome.
    Tan HL; Smith JG; Hoffmann J; Renton T
    Cephalalgia; 2022 Feb; 42(2):128-161. PubMed ID: 34404247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological and non-pharmacological management of burning mouth syndrome: A systematic review.
    Reyad AA; Mishriky R; Girgis E
    Dent Med Probl; 2020; 57(3):295-304. PubMed ID: 33113291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome.
    Danhauer SC; Miller CS; Rhodus NL; Carlson CR
    J Orofac Pain; 2002; 16(4):305-11. PubMed ID: 12455431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of burning mouth syndrome: A review and update.
    Mínguez Serra MP; Salort Llorca C; Silvestre Donat FJ
    Med Oral Patol Oral Cir Bucal; 2007 Aug; 12(4):E299-304. PubMed ID: 17664916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to topical clonazepam in patients with burning mouth syndrome: a clinical study.
    Rodríguez de Rivera Campillo E; López-López J; Chimenos-Küstner E
    Bull Group Int Rech Sci Stomatol Odontol; 2010 May; 49(1):19-29. PubMed ID: 22750263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of acupuncture versus clonazepam in patients with burning mouth syndrome.
    Jurisic Kvesic A; Zavoreo I; Basic Kes V; Vucicevic Boras V; Ciliga D; Gabric D; Vrdoljak DV
    Acupunct Med; 2015 Aug; 33(4):289-92. PubMed ID: 25987645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes and related clinical characteristics in patients with burning mouth syndrome.
    Kim MJ; Kim J; Kho HS
    Oral Dis; 2021 Sep; 27(6):1507-1518. PubMed ID: 33098162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis of burning mouth syndrome therapy.
    Hens MJ; Alonso-Ferreira V; Villaverde-Hueso A; Abaitua I; Posada de la Paz M
    Community Dent Oral Epidemiol; 2012 Apr; 40(2):185-92. PubMed ID: 22044166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of reticular oral lichen planus patients with burning mouth syndrome-like oral symptoms: a pilot study.
    Adamo D; Mignogna MD; Pecoraro G; Aria M; Fortuna G
    J Dermatolog Treat; 2018 Sep; 29(6):623-629. PubMed ID: 29308937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a combination of N-acetylcysteine and clonazepam to treat burning mouth syndrome.
    Han S; Lim JH; Bang J; Cho JH
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Nov; 132(5):532-538. PubMed ID: 34479835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review of randomized trials for the treatment of burning mouth syndrome.
    Kisely S; Forbes M; Sawyer E; Black E; Lalloo R
    J Psychosom Res; 2016 Jul; 86():39-46. PubMed ID: 27302545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burning mouth syndrome: a review of therapeutic approach.
    Nosratzehi T
    J Complement Integr Med; 2021 Dec; 19(1):83-90. PubMed ID: 34881535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose naltrexone for treatment of burning mouth syndrome.
    Sangalli L; Miller CS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Apr; 135(4):e83-e88. PubMed ID: 35851249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A diagnostic and therapeutic approach to primary burning mouth syndrome.
    Moghadam-Kia S; Fazel N
    Clin Dermatol; 2017; 35(5):453-460. PubMed ID: 28916026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characterization and treatment outcome of patients with burning mouth syndrome.
    Hakeem A; Fitzpatrick SG; Bhattacharyya I; Islam MN; Cohen DM
    Gen Dent; 2018; 66(3):41-47. PubMed ID: 29714699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis: A meta-analysis.
    Liu J; Chen F; Wei Z; Qiu M; Li Z; Dan H; Chen Q; Jiang L
    Oral Dis; 2018 Jul; 24(5):706-716. PubMed ID: 28737007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.